Literature DB >> 8070010

Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds.

A Ramu1, N Ramu.   

Abstract

We have previously reported that multidrug (MDR)-reversal activity can be exerted by compounds in which two ring structures of certain types are connected by one alkyl bridge to a secondary or tertiary amine group. In the present investigation we studied the MDR-reversal activity of compounds in which the two ring structures were connected by separate alkyl bridges to the amine group. The structure-activity relationship of these compounds verified previous findings on the structural features that support MDR-reversal activity as well as the features that reduce such activity. In addition, the present study reveals additional chemical groups and ring structures that support MDR-reversal activity as well as those that reduce it.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070010     DOI: 10.1007/bf00685568

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  8 in total

Review 1.  Pharmacology of drugs that alter multidrug resistance in cancer.

Authors:  J M Ford; W N Hait
Journal:  Pharmacol Rev       Date:  1990-09       Impact factor: 25.468

Review 2.  Non-chemotherapeutic agents that potentiate chemotherapy efficacy.

Authors:  D J Stewart; W K Evans
Journal:  Cancer Treat Rev       Date:  1989-03       Impact factor: 12.111

3.  Structure-activity study and design of multidrug-resistant reversal compounds by a computer automated structure evaluation methodology.

Authors:  G Klopman; S Srivastava; I Kolossvary; R F Epand; N Ahmed; R M Epand
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

4.  Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.

Authors:  A Ramu; D Glaubiger; Z Fuks
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

5.  Reversal of multidrug resistance by phenothiazines and structurally related compounds.

Authors:  A Ramu; N Ramu
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study.

Authors:  N Ramu; A Ramu
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

7.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

8.  Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.

Authors:  A Ramu; R Spanier; H Rahamimoff; Z Fuks
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

  8 in total
  3 in total

1.  Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2).

Authors:  A R Alexanian; N S Arutyunian
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Prediction of P-glycoprotein inhibitors with machine learning classification models and 3D-RISM-KH theory based solvation energy descriptors.

Authors:  Vijaya Kumar Hinge; Dipankar Roy; Andriy Kovalenko
Journal:  J Comput Aided Mol Des       Date:  2019-11-19       Impact factor: 3.686

3.  In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions.

Authors:  Sergey Shityakov; Carola Förster
Journal:  Adv Appl Bioinform Chem       Date:  2014-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.